Literature DB >> 7852105

Brain tumors in children: long-term survival after radiation treatment.

D Jenkin1, M Greenberg, H Hoffman, B Hendrick, R Humphreys, A Vatter.   

Abstract

PURPOSE: To determine the cause of death in children who survive more than 5 years after radiation treatment of a brain tumor. METHODS AND MATERIAL: Nine hundred and twelve consecutive children with a primary brain tumor irradiated at the Princess Margaret Hospital or Toronto-Bayview Regional Cancer Center from 1958 to 1991, were evaluated for long-term outcome.
RESULTS: Overall 10- and 20-year survival rates were 44% and 37%. Subsequent survival of 377 5-year survivors was, at an additional 10 and 20 years, 78% and 67%. Most (83%) deaths that occurred more than 5 years from diagnosis were a result of relapse of the original tumor. The 10-year survival rate subsequent to relapse was 9% when the first relapse occurred less than one year from diagnosis, 17% for 1-2 years, and 31% when the time to relapse was 3 years or greater. The cumulative actuarial incidence of, and death from, second malignant tumors at 30 years from diagnosis was 18% and 13%, respectively.
CONCLUSIONS: Death later than 5 years from diagnosis of a brain tumor in children is common and is usually due to progressive disease in slowly evolving low grade tumors. Death from a second malignant tumor becomes more frequent than death from the original tumor after 15 years from diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 7852105     DOI: 10.1016/0360-3016(94)00393-Y

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  The results of radiotherapy for brainstem tumors.

Authors:  S E Schild; S L Stafford; P D Brown; C P Wood; B W Scheithauer; P J Schomberg; W W Wong; M K Lyons; E G Shaw
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

2.  Hodgkin's lymphoma in an adolescent previously treated with surgical resection of third ventricular juvenile pilocytic astrocytoma.

Authors:  Dillon Y Chen; John Ross Crawford
Journal:  BMJ Case Rep       Date:  2015-06-25

3.  Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology.

Authors:  Kimberly R Porter; Bridget J McCarthy; Sally Freels; Yoonsang Kim; Faith G Davis
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

4.  Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM).

Authors:  Daniel Bejarano-Quisoboni; Nathalie Pelletier-Fleury; Rodrigue S Allodji; Brigitte Lacour; Pascale GrosClaude; Hélène Pacquement; François Doz; Delphine Berchery; Claire Pluchart; Piere-Yves Bondiau; Julie Nys; Angela Jackson; Charlotte Demoor-Goldschmidt; Agnès Dumas; Cécile Thomas-Teinturier; Giao Vu-Bezin; Dominique Valteau-Couanet; Nadia Haddy; Brice Fresneau; Florent de Vathaire
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

5.  Microscopic Delineation of Medulloblastoma Margins in a Transgenic Mouse Model Using a Topically Applied VEGFR-1 Probe.

Authors:  Danni Wang; Ye Chen; Steven Y Leigh; Henry Haeberle; Christopher H Contag; Jonathan T C Liu
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

6.  Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

Authors:  Roger J Packer; Tianni Zhou; Emi Holmes; Gilbert Vezina; Amar Gajjar
Journal:  Neuro Oncol       Date:  2012-10-25       Impact factor: 12.300

7.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.

Authors:  Africa Fernandez-L; Paul A Northcott; James Dalton; Charles Fraga; David Ellison; Stephane Angers; Michael D Taylor; Anna Marie Kenney
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

8.  Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.

Authors:  Danny Rogers; Karen D Nylander; Zhiping Mi; Tong Hu; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-13       Impact factor: 3.333

9.  [Brain tumors in childhood].

Authors:  M Sinzig; J Gasser; B Jauk; K A Hausegger
Journal:  Radiologe       Date:  2008-10       Impact factor: 0.635

Review 10.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.